JAZZ PHARMACEUTICALS FRANCE
- Country
- 🇫🇷France
- Ownership
- -
- Established
- 2003-01-01
- Employees
- -
- Market Cap
- -
Safety and Tolerability of Cannabidivarin (CBDV) in Children and Young Adults With Autism Spectrum Disorder
- First Posted Date
- 2019-02-21
- Last Posted Date
- 2022-09-02
- Lead Sponsor
- Jazz Pharmaceuticals
- Target Recruit Count
- 1
- Registration Number
- NCT03849456
- Locations
- 🇺🇸
Clinical Trial Site, Columbus, Ohio, United States
A Trial to Evaluate the Potential Impact of Renal Impairment on the Pharmacokinetics and Safety of CPX-351
- Conditions
- Interventions
- First Posted Date
- 2018-06-14
- Last Posted Date
- 2021-07-22
- Lead Sponsor
- Jazz Pharmaceuticals
- Target Recruit Count
- 21
- Registration Number
- NCT03555955
- Locations
- 🇺🇸
Baylor University Medical Center, Dallas, Texas, United States
🇺🇸Northside Hospital - Blood and Bone Marrow Transplant Group of Georgia, Atlanta, Georgia, United States
🇺🇸Georgetown University Medical Center, Washington, District of Columbia, United States
A Multicenter Study of the Efficacy and Safety of JZP-258 in the Treatment of Idiopathic Hypersomnia (IH) With an Open-label Safety Extension
- Conditions
- Interventions
- First Posted Date
- 2018-05-22
- Last Posted Date
- 2021-11-24
- Lead Sponsor
- Jazz Pharmaceuticals
- Target Recruit Count
- 154
- Registration Number
- NCT03533114
- Locations
- 🇺🇸
PAB Clinical Research, Brandon, Florida, United States
🇺🇸Bronson Methodist Hospital, Kalamazoo, Michigan, United States
🇺🇸Center for Sleep & Wake Disorders, Chevy Chase, Maryland, United States
A Post-Marketing Observational Study of VYXEOS™
- Conditions
- Interventions
- First Posted Date
- 2018-05-16
- Last Posted Date
- 2020-08-05
- Lead Sponsor
- Jazz Pharmaceuticals
- Target Recruit Count
- 52
- Registration Number
- NCT03526926
- Locations
- 🇺🇸
Ochsner Clinic Foundation, New Orleans, Louisiana, United States
🇺🇸Tulane University Hospital & Clinic, New Orleans, Louisiana, United States
🇺🇸Franciscan Physician Network Oncology and Hematology Specialists, Indianapolis, Indiana, United States
A Phase 2 Study of CX-8998 in Adults With Tremor Associated With Parkinson's Disease
- First Posted Date
- 2018-02-19
- Last Posted Date
- 2021-05-28
- Lead Sponsor
- Jazz Pharmaceuticals
- Registration Number
- NCT03436953
CX-8998 for Absence Seizures
- First Posted Date
- 2018-01-23
- Last Posted Date
- 2022-09-08
- Lead Sponsor
- Jazz Pharmaceuticals
- Target Recruit Count
- 7
- Registration Number
- NCT03406702
- Locations
- 🇺🇸
Arkansas Epilepsy Program, Little Rock, Arkansas, United States
🇺🇸Tufts Medical Center, Boston, Massachusetts, United States
🇺🇸NYU Comprehensive Epilepsy Center, New York, New York, United States
An Open-Label Study of Defibrotide for the Prevention of Acute Graft-versus-Host-Disease (AGvHD)
- Conditions
- Interventions
- First Posted Date
- 2017-11-13
- Last Posted Date
- 2021-08-18
- Lead Sponsor
- Jazz Pharmaceuticals
- Target Recruit Count
- 152
- Registration Number
- NCT03339297
- Locations
- 🇦🇹
Universitätsklinikum Innsbruck, Innsbruck, Austria
🇭🇷Klinichki Bolnicki Centar Zagreb, Zagreb, Croatia
🇩🇪Uniklinik Köln, Köln, Germany
A Phase 2 RCT Study of CX-8998 for Essential Tremor
- First Posted Date
- 2017-04-05
- Last Posted Date
- 2021-11-23
- Lead Sponsor
- Jazz Pharmaceuticals
- Target Recruit Count
- 95
- Registration Number
- NCT03101241
- Locations
- 🇺🇸
Wake Research Associates, LLC, Raleigh, North Carolina, United States
🇺🇸Woodland International Research Group, Little Rock, Arkansas, United States
🇺🇸St. Louis Clinical Trials, Saint Louis, Missouri, United States
A 4-Week Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness
- Conditions
- Interventions
- First Posted Date
- 2017-01-31
- Last Posted Date
- 2020-01-09
- Lead Sponsor
- Jazz Pharmaceuticals
- Target Recruit Count
- 66
- Registration Number
- NCT03037203
- Locations
- 🇺🇸
Bioclinica Research, Orlando, Florida, United States
🇺🇸PAB Clinical Research, Brandon, Florida, United States
🇺🇸MD Clinical, Hallandale Beach, Florida, United States
European VOD Registry
- Conditions
- First Posted Date
- 2017-01-26
- Last Posted Date
- 2019-10-16
- Lead Sponsor
- Jazz Pharmaceuticals
- Target Recruit Count
- 176
- Registration Number
- NCT03032016
- Locations
- 🇫🇷
CHU d'Estaing, Clermont Ferrand, France
🇫🇷IHOP, Lyon, France
🇫🇷Hôpital d'enfants de la Timone, Mare aux Daims, France